Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

NCT00792727 is registered in ClinicalTrials.gov with Hisamitsu Pharmaceutical Co., Inc. as lead sponsor.

NCT NCT00792727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00792727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee
Lead sponsor
Hisamitsu Pharmaceutical Co., Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
May 31, 2008
Enrollment
380 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee